3-[3-[3-[[5-(4-Methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]propyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]-5-methyl-1,2-oxazole

InChIKey	`HMXWHDMFAKYACA-UHFFFAOYSA-N`
Compound Name	3-[3-[3-[[5-(4-Methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]propyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]-5-methyl-1,2-oxazole
Canonical SMILES	`COc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	7.83
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P35462	DRD3	Homo sapiens	Human	PF00001	9.4	Ki	ChEMBL
Q12809	KCNH2	Homo sapiens	Human	PF00027 PF00520 PF13426	7.4	IC50	ChEMBL;BindingDB
P14416	DRD2	Homo sapiens	Human	PF00001	6.7	Ki	ChEMBL